Andrew Fieldman

Mentioned in 11 analyzed podcast episodes across 10 shows

Appears On

The Last Invention is AI The Daily AI The AI Podcast Personal AI No Priors AI Latent Space AI Global News Podcast Claude AI Building AI: News on OpenAI's ChatGPT, Anthropic's Claude, Google Gemini and xAI's Grok AI Breakdown

Episode Appearances

The Last Invention is AI · May 14, 2026

Anthropic + Gates Give $200M to Healthcare | Cerebras IPO Doubles

“Cerebras CEO whose stake is now worth $1.9B following IPO first-day doubling”

AI Healthcare Deployment and Global Health EquityAI Chip Company IPO Valuations and Market DynamicsMicrosoft OpenAI Relationship and Vendor Diversification

View Analysis

The Daily AI · May 14, 2026

Anthropic + Gates Give $200M to Healthcare | Cerebras IPO Doubles

“Cerebras CEO whose stake is worth approximately $1.9B following IPO first-day stock doubling”

AI in Global Health and Life SciencesAI Chip IPO Market DynamicsCompute Infrastructure and GPU Allocation

View Analysis

The AI Podcast · May 14, 2026

Anthropic + Gates Give $200M to Healthcare | Cerebras IPO Doubles

“Cerebras CEO whose stake is now worth ~$1.9B following company's IPO that doubled on first day”

AI in Global Health and Life SciencesFrontier AI Model IPOs and ValuationsAI Chip Supply Chain and Semiconductor Demand

View Analysis

Personal AI · May 14, 2026

Anthropic + Gates Give $200M to Healthcare | Cerebras IPO Doubles

“Cerebras CEO whose stake is now worth $1.9B following company's IPO doubling on first day of trading”

Foundation Model Deployment in HealthcareAI Chip IPO Valuations and Market DynamicsVertical SaaS Competition from Foundation Models

View Analysis

No Priors AI · May 14, 2026

Anthropic + Gates Give $200M to Healthcare | Cerebras IPO Doubles

“Cerebras CEO whose stake is now worth ~$1.9B following company's 108% first-day IPO pop to $56.4B valuation”

Anthropic and Gates Foundation Healthcare PartnershipCerebras IPO Pricing Strategy and First-Day PerformanceMicrosoft Diversification from OpenAI Dependency

View Analysis

Latent Space AI · May 14, 2026

Anthropic + Gates Give $200M to Healthcare | Cerebras IPO Doubles

“Cerebras CEO whose stake is now worth approximately $1.9B following company's IPO and first-day stock doubling”

AI in Global Health and Life SciencesFoundation Model Company IPOs and ValuationsAI Chip Manufacturing and Supply Chain

View Analysis

Global News Podcast · May 14, 2026

Anthropic + Gates Give $200M to Healthcare | Cerebras IPO Doubles

“Cerebras CEO whose stake is now worth approximately $1.9B following company's IPO and first-day stock doubling”

AI Model Deployment in HealthcareAI Chip Company IPOs and ValuationsOpenAI Competitive Alternatives

View Analysis

Claude AI · May 14, 2026

Anthropic + Gates Give $200M to Healthcare | Cerebras IPO Doubles

“Cerebras CEO whose stake is now worth approximately $1.9B following IPO first-day doubling”

AI in Healthcare and Global Health DeploymentAI Chip IPO Valuations and Market PerformanceMicrosoft OpenAI Relationship and Vendor Diversification

View Analysis

Building AI: News on OpenAI's ChatGPT, Anthropic's Claude, Google Gemini and xAI's Grok · May 14, 2026

Anthropic + Gates Give $200M to Healthcare | Cerebras IPO Doubles

“Cerebras CEO whose stake is now worth approximately $1.9B following company's IPO doubling”

Anthropic Healthcare Deployment StrategyCerebras IPO Valuation and Market ReceptionMicrosoft OpenAI Diversification Strategy

View Analysis

AI Breakdown · May 14, 2026

Anthropic + Gates Give $200M to Healthcare | Cerebras IPO Doubles

“Cerebras CEO whose stake is worth approximately $1.9B following company's IPO and first-day stock doubling”

Anthropic and Gates Foundation Healthcare PartnershipCerebras IPO and AI Chip Company ValuationsMicrosoft OpenAI Diversification Strategy

View Analysis

Anthropic · May 14, 2026

Anthropic + Gates Give $200M to Healthcare | Cerebras IPO Doubles

“Cerebras CEO whose stake is now worth approximately $1.9B following company's IPO and 108% first-day stock pop”

AI in Global Health and Life SciencesHealthcare AI Deployment BenchmarkingAI Chip Company IPOs and Valuations

View Analysis